Bureau Veritas adds ESG metrics to loan and restarts dividend

biotech_microscope_drug_production_adobe_575x375_oct13
By Mike Turner
25 Feb 2021

Bureau Veritas, the French laboratory testing company, has amended its €600m bank line to include ESG elements, as the company is on course to breeze through its relaxed covenant restrictions at the next evaluation.

The margin on the facility is now linked to three key performance indicators. It means the company will get cheaper financing if women are in 35% of the company’s leadership positions (up from 19.5%), and if it cuts its total accident rate by 32% and reduces its annual ...

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free trial

Want to learn more? View subscription options